Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
Symbol Lookup
: Stock Quote & Summary Data
$ 2.58
0.06
2.38%
2.38%
TTHI | Transition Therapeutics, Inc. | (Canada) Ordinary Shares | Market : NASDAQ-GM
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 146,329 |
| Previous Close | $ 2.52 |
| 52 Wk High / Low | $ 9 / $ 2.34 |
| Shares Outstanding | 23,218,000 |
| Market Value | $ 59,902,440 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 1.19 |
| NASDAQ Official Open Price: | $ 2.93 |
| Date of NASDAQ Official Open Price: | Feb. 9, 2010 |
| NASDAQ Official Close Price: | $ 2.53 |
| Date of NASDAQ Official Close Price: | Feb. 8, 2010 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About TTHI?
Ask your question about about Transition Therapeutics, Inc. (TTHI) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
No business description found.
Links to all Transition Therapeutics, Inc. (TTHI) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Get ETF News, Commentary, Tools & more...
Company News for TTHI |
||
|
Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2010 Financial Results on Wednesday, February 10th, at 4:30 P.M. EST - GlobeNewswire 02/08/2010 7:01AM |
||
|
Transition Therapeutics Announces Participation in 12th Annual BIO CEO & Investor Conference - GlobeNewswire 02/05/2010 1:31PM |
||
|
Transition Therapeutics Reports Positive Result For Phase II Study Of TT-223 In Type 2 Diabetes - Update - RTT News 01/25/2010 8:24AM |
||
|
Transition Therapeutics Announces Results of a Phase 2 Study of TT-223 in Type 2 Diabetes Patients - GlobeNewswire 01/25/2010 6:01AM |
||
|
The Complete List of Canadian Stocks Traded on the Nasdaq - Seeking Alpha 12/21/2009 3:41PM |
